Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 11,283 | 14,540 | 8,043 | 3,738 | 5,213 |
| Operating Income | -11,283 | -14,540 | -8,043 | -3,738 | -5,213 |
| Other Income | -413 | 4,052 | 4,440 | 7 | 62 |
| Pre-tax Income | -11,696 | -10,488 | -3,603 | -3,731 | -5,151 |
| Net Income Continuous | -11,696 | -10,488 | -3,603 | -3,731 | -5,151 |
| Minority Interests | -44 | -111 | -51 | N/A | N/A |
| Net Income | $-11,652 | $-10,377 | $-3,552 | $-3,731 | $-5,151 |
| EPS Basic Total Ops | -15.79 | -73.48 | -122.56 | -247.37 | -349.45 |
| EPS Basic Continuous Ops | -9.03 | -74.38 | -123.98 | -247.60 | -351.78 |
| EPS Diluted Total Ops | -15.79 | -73.48 | -122.56 | -247.37 | -349.45 |
| EPS Diluted Continuous Ops | -9.03 | -74.38 | -123.98 | -247.60 | -351.78 |
| EPS Diluted Before Non-Recurring Items | -15.79 | -73.68 | -122.56 | -248.00 | -349.45 |
| EBITDA(a) | $-11,283 | $-14,540 | $-8,043 | $-3,738 | $-5,213 |